🔎 Trials Near Me

ホーム › 血液がん › ニューヨーク

ニューヨークにおける血液がんの臨床試験

ニューヨーク内の拠点で、血液がんに関する29件の研究が参加者を募集しています。

ニューヨーク内の都市

公式研究テキスト(英語)

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0032), New York
  • White Plains Hospital-Center for Cancer Care ( Site 0069), White Plains
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT03486873

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Queens Hospital Center, Jamaica
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • Stony Brook University Medical Center, Stony Brook
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069

A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

  • NYU Langone Health, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07572006

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

  • Mount Sinai Medical Center, New York
  • University of Rochester Medical Center, Rochester
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT04634552

Genomic Profiling in Cancer Patients

  • Kings County Hopsital Center, Brooklyn
  • Memorial Sloan Kettering Cancer Commack, Commack
  • Memorial Sloan Kettering Westchester, Harrison
  • 他7件
被験者募集中観察研究
全年齢 · 全性別 · 2026/09/24更新 · NCT01775072

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

  • Quetzal Site 4, Buffalo
  • Quetzal Site 2, The Bronx
被験者募集中第3相
18歳〜71歳 · 全性別 · 2026/09/23更新 · NCT07504458

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • NYU Langone Hospital - Long Island, Mineola
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

  • David H. Koch Center for Cancer Care, New York
  • Montefiore Medical Center PRIME, The Bronx
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/21更新 · NCT07648264

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

  • Hematology Oncology Associates of Central New York-Auburn, Auburn
  • Roswell Park Cancer Institute, Buffalo
  • Hematology Oncology Associates of CNY at Camillus, Camillus
  • 他5件
被験者募集中観察研究
全年齢 · 全性別 · 2026/09/17更新 · NCT04242095

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

  • Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/15更新 · NCT07195916

A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies

  • Research Site, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/24更新 · NCT07220616

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

  • State University of New York at Buffalo, Buffalo
  • Icahn School of Medicine at Mount Sinai, New York
  • Columbia University, New York
  • 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/20更新 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • Northwell Health, LLC PRIME, Lake Success
  • Memorial Sloan Kettering Cancer Center, New York
  • 他3件
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/20更新 · NCT06001788

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

  • Northwell Health, Manhasset
  • NYP/Weill Cornell Medical Center, New York
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/08/17更新 · NCT04515810

A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant

  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/07更新 · NCT07359859

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

  • Weill Cornell Medicine - New York Presbyterian Hospital, New York
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/07更新 · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Roswell Park Cancer Institute, Buffalo
  • North Shore University Hospital, Lake Sucess
  • Cohen Children's Medical Center of New York, New Hyde
  • 他9件
被験者募集中観察研究
全年齢 · 全性別 · 2026/07/06更新 · NCT01351545

A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

  • Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • New York University (Data Collection Only), New York
  • 他2件
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/29更新 · NCT07006506

IVIG for Infection Prevention After CAR-T-Cell Therapy

  • Memorial Sloan Kettering Cancer Center, New York
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/29更新 · NCT05952804

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

  • New York Presbyterian Hospital, New York
  • Mt Sinai Medical Center, New York
被験者募集中第3相
18歳以上 · 全性別 · 2026/06/11更新 · NCT06401356

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

  • Mount Sinai Hospital, New York
  • Memorial Sloan Kettering Cancer Center, New York
被験者募集中観察研究
18歳以上 · 全性別 · 2026/06/01更新 · NCT05663502

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

  • Memorial Sloan Kettering Cancer Center Suffolk - Commack (All protocol activities), Commack
  • Memorial Sloan Kettering Westchester (All protocol activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All protocol activities), New York
  • 他1件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/05/26更新 · NCT07052916

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • Mt Sinai, New York
  • Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/16更新 · NCT03328078

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • New York - Presbyterian / Weill Cornell Medicine, New York
  • Mount Sinai - Ruttenberg Treatment Center, New York
  • 他2件
被験者募集中第1相
18歳以上 · 全性別 · 2026/03/13更新 · NCT05735184

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

  • Memorial Sloan Kettering Cancer Center, New York
被験者募集中観察研究
18歳以上 · 全性別 · 2026/01/23更新 · NCT07362225

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

  • Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2025/04/15更新 · NCT06462365

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Children's Hospital New York-Presbyterian, New York
  • Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
1歳〜21歳 · 全性別 · 2024/12/06更新 · NCT05476770

Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT

  • Memorial Sloan Kettering Cancer Center (MSKCC), New York
被験者募集中第1/2相
全年齢 · 全性別 · 2023/03/06更新 · NCT04959903

The Leukemia and Lymphoma Society (LLS) National Research Registry

  • Lymphoma and Leukemia Society, Rye Brook
被験者募集中観察研究
21歳以上 · 全性別 · 2022/04/07更新 · NCT04806295

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。